Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Endometriosis Stories

2012-12-21 05:01:28

Endometriosis is a painful, sometimes disabling disease that attacks a woman´s reproductive tract and other pelvic organs and can ultimately lead to infertility and chronic pelvic pain (CPP). Women´s Excellence in Endometriosis is a one-of-a-kind, specialty center for woman suffering with the disease and its painful sequelae. Oakland County, MI (PRWEB) December 20, 2012 Women with chronic pelvic pain (CPP) may likely have a condition called “Endometriosis.”...

2012-10-31 15:25:31

SAN DIEGO, Oct. 31, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter and nine months ended September 30, 2012. For the third quarter of 2012, the Company reported a net loss of $3.1 million, or $0.05 loss per share, compared to net income of $31.4 million, or income of $0.56 per fully diluted share outstanding, for the same period in 2011. For the nine months ended September 30, 2012, the Company reported a net loss of $4.5...

2012-10-24 19:21:14

SAN DIEGO, Oct. 24, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its third quarter 2012 financial results after the Nasdaq market closes on Wednesday, October 31, 2012. Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Wednesday afternoon, October 31, 2012 at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Participants can access the live conference...

2012-10-11 04:00:54

Synechion, Inc., a research and consulting company specializing in the prevention of adhesions - internal scars causing pain and other complications - has announced the formation of a new company, KevMed, LLC to commercialize break-through innovations for the treatment of chronic pelvic pain and related disorders. Over 15 million patients in the U.S. suffer from chronic pelvic pain with very few effective treatment options currently available. Dallas, TX, (PRWEB) October 10, 2012 Synechion...

2012-10-03 23:00:49

In honor of Adhesion Related Disorders Awareness Month, Clear Passage Physical Therapy is launching the “Sharing Is Caring” giveaway and social media awareness campaign. Gainesville, FL (PRWEB) October 02, 2012 In honor of Adhesion Related Disorder Awareness Month (September), the online community is asked to share an inspirational video of stories and testimonials about a hands-on therapy that can serve as a relatively inexpensive surgery alternative for people with adhesions....

Continuous Oral Contraception Offers More Comfort For Menstrual Cramps Than Other Methods
2012-08-16 11:47:05

Connie K. Ho for redOrbit.com — Your Universe Online Premenstrual syndrome can be a difficult time of the month for females. Recently, researchers sought to study the effects of different contraceptive methods on the menstrual cycle. Scientists at Penn State College of Medicine recently discovered that women who take oral contraceptive on a continuous basis, rather than during each menstrual cycle, have relief for moderate to severe cramps at an earlier rate. The cramps, known...

2012-07-31 10:26:00

SAN DIEGO, July 31, 2012 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended June 30, 2012. For the second quarter of 2012, the Company reported a net loss of $0.5 million, or $0.01 loss per share, compared to net income of $2.0 million, or $0.04 per share, for the same period in 2011. For the six months ended June 30, 2012, the Company reported a net loss of $1.4 million, or $0.02 loss per share, as compared to net income of...

2012-06-11 23:03:58

Clear Passage Physical Therapy® has launched a mobile version of its website. Viewable on smartphones and tablet devices, the mobile-ready website will help the nearly 30% of web visitors who request information or services via mobile devices. Clear Passage is a unique network of U.S.-based physical therapy clinics that has sparked huge interest as a result of its non-surgical, drug-free therapy for infertility, bowel obstruction and chronic pain. Gainesville, FL (PRWEB) June 11, 2012...

2012-06-05 02:28:04

ABBOTT PARK, Ill., June 5, 2012 /PRNewswire/ -- Abbott (NYSE: ABT), in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis. Elagolix is an oral gonadotropin-releasing hormone (GnRH) antagonist. "Endometriosis can be a debilitating disease that affects millions of women around the world and the exploration of new...

2012-05-14 22:20:48

LAUSANNE and VILLARS-SUR-GLÂNE, Switzerland, May 15, 2012 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm) and Vifor Pharma announce the signing of an exclusive agreement covering the distribution and commercialization in Switzerland of the 1-, 3- and 6-month formulations of Pamorelin(R)LA and of the 3-month formulation of Salvacyl(R). The agreement came into effect on 9 May 2012. Pamorelin(R) LA, which contains the active substance triptorelin in the form of...